James Cosgrove, DO
Obstetrics & Gynecology · Darby, PANPI 1881631562
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by AbbVie at 42.9% of the total. Reporting peaked in 2022 at $4,657 and has fallen 99.2% since, to $39 in 2025. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $92.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Intuitive Surgical$2K
- Medtronic$247
- Duchesnay USA Incorporated$151
- Johnson & Johnson$124
- Exact Sciences$116
- plus $630 from 18 others
What the payments were for
- Speaking & faculty fees$2,40041%
- Travel & lodging$73013%
- Food & beverage$1,58327%
- Education$1,09319%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 7 | $2,492 |
| Intuitive Surgical | 11 | $2,046 |
| Medtronic | 4 | $247 |
| Duchesnay USA Incorporated | 4 | $151 |
| Johnson & Johnson | 2 | $124 |
| Exact Sciences | 5 | $116 |
| Lupin Inc. | 2 | $83 |
| Covidien LP | 3 | $68 |
| Bayer | 3 | $59 |
| AMAG Pharmaceuticals, Inc. | 4 | $57 |
| Therapeuticsmd, Inc. | 2 | $49 |
| Amgen | 2 | $48 |
| Mylan Pharmaceuticals Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| BD | 1 | $29 |
| Dysis Medical, Inc. | 1 | $28 |
| Smith+Nephew | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Pfizer | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$2,400
- DAVINCI XI$1,000
- Da Vinci Surgical System$926
- Osphena$122
- TruClear$110
How this compares
$5,806 in reported general payments places this provider in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 14 | $346 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Darby
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
- Catherine ChappellPittsburgh$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.